{"name":"Pulmatrix Inc.","slug":"pulmatrix-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9nSDdFZ09LM2JiNzg0cllhUXZhMnlNQTZKQlJZcmRkS3lxWTdweHlMQXpmdzRSS0FKOGlpWmEtSjRGQ3BiVExlOWJKM3o0aXozUk1JUUw2MU9EVmZGRmRWeDNPbjUtOXhoYXFmX25B?oc=5","date":"2026-04-06","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in Pulmatrix (PULM) - Stock Titan","headline":"If You Invested $1,000 in Pulmatrix (PULM)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygJBVV95cUxQWTJVTGh0ejN2YjM1TlN0dzlINUI2X0dubnVSWHdzTGxaZFBRM3RqNm14LWdMWERyamxIbW1YTHZLRWhpbDhDR3dFNHIwSWxMWGZOQXBweEpPdG9qakYwNUoySzZZN0lQQlV2a1FDX0Z0ZmxDYlREY0tmSVpYYkR6YjY4OWlseUFTWmF3VG1fMElGeXNTczZsTEFFdFpOTy1JN3ZJMnd5NGFTNXpaeXRINnNkWVBTVW1zbUlwZGNROUZnR0xvcXpLcFh1dXdmMEFMUGJYU2dMNV9Zdm9VcktZMUU4WUQzZmxrcEdqVXRQT1RtbWhlS1NZYTk0WmVqWUdZakhvZGIwaVdMVU84MDAyNkVZOFhlNkRFODR5T2ZzTzQzOWpPMjF0cktlcDVZNl9Nc0hkbWc5ZldWZm1iSlVNaWx3aURiWF9lUnc?oc=5","date":"2026-03-26","type":"pipeline","source":"Barchart.com","summary":"Asthma Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | GlaxoSmithKline, AB Science, Areteia Therapeutics, ARS Pharma, AstraZeneca, Pieris Pharma, Sanofi, Cumberland Pharma - B","headline":"Asthma Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | GlaxoSmithKline, AB Science, Areteia The","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgJBVV95cUxQbkk4RVM2cUo5VGtyaWdnc3RMSG53bUlMbEtNb2dyZHcwWEd1M3BJaGIzclhvTzFhLUJXQlJlRXpLLS15bWN5MkRWMXE4YzNxX00tZEk5ZGp2ZWtkdUduUHV0eE9wY0p0Sm5DYzZNTHd4QjdWdS1lTU5UMVo3U0tKUEl4eE5DcmhkbXhXbGRMbmxXOFN0aVJXUl9wVlRwdTJfTnMzU1hoT0VBTG4xeFA3WW1UOFJNTEJ1VEpJMmFPNlN6SDBFWXJ0bGQwN0lRaDYxX2tQZl9XOXJ6ZGp4U3Vpby1mUDhmMzFrbVMwU01ycnlWZEh3NkVMSTN6SkEyc2lzRnpKeUVFSDRRc3N1WjV1WWxKOERXSkI1cmxjVmh0VndTWjRuTmNqM095cW1Jc2pVcUFRRkU4TGFjOXN3UlBianctbUxfb1NhMWF5Z1BR?oc=5","date":"2026-03-26","type":"pipeline","source":"Barchart.com","summary":"Asthma Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | GlaxoSmithKline, AB Science, Areteia Therapeutics, ARS Pharma, AstraZeneca, Pieris Pharma, Sanofi, Cumberland Pharma - B","headline":"Asthma Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | GlaxoSmithKline, AB Science, Areteia The","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNeWtIc3BmWFE3dDVvb01MenRianVWSWlVZjNmV0hvV1YtUnFlZWNnNE5zTUFlYjJveU9ETFNfMjFScGRRcE9pSUQxbW9sMkN0dUlhZDNTUzBnSHF1bzdaSkVqWVNVUWpVcmF6VGQ4aVpJRUFjVlpIWHRLR2EyNmFpWC1XbHNIWVZjV0tVaGkzTjdScXkyTWczQWdR?oc=5","date":"2026-03-02","type":"deal","source":"Contract Pharma","summary":"Pulmatrix and Cullgen Terminate Merger Agreement - Contract Pharma","headline":"Pulmatrix and Cullgen Terminate Merger Agreement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxNODNCTkJBNVEtWi1mQlN5ZmZFdHNmQVNBZ0VoNU0tY3dBQmtlNlFoOEFmR0J5b3ktb1pMdl80VEIwSlR6bVJETEpLQXV4UHJGM1ZuSG5yc2Jqcno1MUdPenBXa2dNdlJHZ0MxTTB6UnNlbkxidFNFbFA2cFVYYVA2R2lPRTJPUkNCMXFfRVVGb2JveTY0dmF0VDFURVA3S2RMNU41R2JzSUFtVUtDOU0xdWNHOUpOWFBPUmxaNU41cmlvUmp2OVVjUnhJcWFicGJqVEIzUDJ5d3dsWVZjRkoyUHoxckFTcmJyak1VcXctSEJFRU5ZcktzYlJR?oc=5","date":"2026-03-02","type":"pipeline","source":"Stocktwits","summary":"Pulmatrix Shares Dive As Privately-Held Pharma Company Chooses To Merge With Gyre Therapeutics Instead - Stocktwits","headline":"Pulmatrix Shares Dive As Privately-Held Pharma Company Chooses To Merge With Gyre Therapeutics Instead","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQbU1uRl81M1B0UEl4Q0JOcGVaekFZQjRkbFp3R1FYdy1HSm51WlppTWNRX1NyRVQtcXNZQzdTaWZRbHQzZm1OVnpOX3g3MHdodDlNdm9aOHNyQUlPWjZrTUQ1Z19DMWtheFd6QTdTT1hLeGQ3TlhMNTE2YVROaU82c3pzMk5aUUxONGw4eGFkN2lvZWh6ZWR6VEtYOUh2VlE?oc=5","date":"2026-03-02","type":"deal","source":"Fierce Biotech","summary":"Cullgen ditches reverse merger with Pulmatrix to go with Gyre in $300M buyout - Fierce Biotech","headline":"Cullgen ditches reverse merger with Pulmatrix to go with Gyre in $300M buyout","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxNcllrZGpoemF0a2Z3eXd2QmVSRGstbGxnTHFwWDFMWjVHWHVEbkIteGQxU1poMzBwWHNUQkJYRnpGSTNRRjZmVWVoWEwtUUJhZmd0dDhXWDFDVFBVOE85UHRRcGQxdHRrR1ptaDVndDBsM0V6Ump2SHVxaTI1M1NNaFNsOHlpMkRQXy1GR1g5TmlFUlNUVEh5TnRQUHgyaUJCWTYyeFU4THp0TER2UkM1Z09jTWNiSHpoNWMwb2NjcGg2Vkc1LWVNT2xVY0laTWF5eGVfX0FPbWdWXzUzUDM5WExFTlF4MTBlRGZzM3hwNGtzSkpYRFV0MHA0Yw?oc=5","date":"2025-10-16","type":"earnings","source":"prnewswire.com","summary":"Pulmatrix Announces Third Quarter 2025 Financial Results and Divestment Plan for Migraine and Inhalation Assets - prnewswire.com","headline":"Pulmatrix Announces Third Quarter 2025 Financial Results and Divestment Plan for Migraine and Inhalation Assets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPMG05QWFkUHJzVm9VaDhVamZ1VWgtSWMyWlI3ZnAtUC1VTUtUYjgxYjFPRkFFVTVMY1BjUk1qcTl6TGduMGIwOEdzclgtTXJZU1pZMGJCOGVSQ0hhOTB6UU5mMEdDOEhVUUE5bFNiNHRuRU1uWmxhZUZOem5LbV8xbE1zdlUwT2ctN0hObk1UZmRlbTREUmJKZ3d3bE44cXhmVGJGMjZBcUdzeWF6Vjc4?oc=5","date":"2024-11-27","type":"deal","source":"San Diego Business Journal","summary":"Cullgen Entering Public Market with Pulmatrix Merger - San Diego Business Journal","headline":"Cullgen Entering Public Market with Pulmatrix Merger","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxOZnc0c0ZhRFJIeThuOHFkOXhma0FGenJ3a2g3RmkzbTJ4N05MVV9hYzg4UWxQMzhQOGZMX2sydDh0djE5SnJzUTRLZjJSamowSGZOdmpUaE5hSVlnV0Z4dDhSOS1rNmNuWi1UWFE0SzBaWFl5M2txVUlBdFJNMy1QQUVoWQ?oc=5","date":"2024-11-13","type":"pipeline","source":"Contract Pharma","summary":"Pulmatrix to Merge with Cullgen - Contract Pharma","headline":"Pulmatrix to Merge with Cullgen","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPeXZ1ZS04SzEzeHhDWU01ZnhZRm5TMlIxaGFqWkM0akhyTFpuMG9RNWZYNFZWWXIxWEVBNkhaa09pRnRxSlNYX3BBRmFYdkZCVlVGZXVCSnVqaDZmQkFubTZwRmRZcGtZUFJaRW5NbnpsaTFSeG5oSTBieHJyRS14UXN5WHpiTWd3b1haSmpJY3VWT1ZhemtWNWxmYm9fQkNqOVlHcQ?oc=5","date":"2024-11-13","type":"deal","source":"prnewswire.com","summary":"Pulmatrix and Cullgen Announce Proposed Merger - prnewswire.com","headline":"Pulmatrix and Cullgen Announce Proposed Merger","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFBvU0xzX2tFZDlIdWJTNXVHU1FCd3QwVlFpTm9uaGI4QUI1dWhjZksxaHE1QkJmVGhCeXJRaXNMdTdOS3hiV1dzeXRVZFZwM0pLVTFabktMX3AxdXNmTFV3Z2FmSHczck85cGhQNnFIaldHelRiU0lZbnFMNzNLUQ?oc=5","date":"2023-12-25","type":"pipeline","source":"respiratory-therapy.com","summary":"Pulmatrix Launches iSPERSE - respiratory-therapy.com","headline":"Pulmatrix Launches iSPERSE - respiratory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxOUGJpcFRjRkVzaklFbWkzRTFPUHlKYnIzVFd6MkVFaVNjc1lDQjhQU0ZzZXg1eXlYdGhHVVhnZjFNTGVMSGZweVBCNFRfc3QxeXB5LTlxZzM2MjlYaVVRb3pvVFBVN3JvRnpKX0NyMERIUlB3Ulh3c1E4YzRHUGpWdWR6dDNLOXM?oc=5","date":"2022-09-26","type":"pipeline","source":"drugdeliverybusiness.com","summary":"Pulmatrix completes patient dosing for inhaled migraine treatment - drugdeliverybusiness.com","headline":"Pulmatrix completes patient dosing for inhaled migraine treatment","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}